Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajat Goyal

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Journal of General Virology|February 21, 2018
Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern IndiaPaneerselvam Nandagopal, Jayanta Bhattacharya, Aylur K Srikrishnan, et al.
Current Pharmaceutical Biotechnology|July 23, 2024
Decoding and Unravelling Mpox, Herpes, and Syphilis Infections: A State of Art ReviewJiao Wang, Rajat Goyal, Rupesh K Gautam, et al.
Retrovirology|May 15, 2021
Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificitiesRanajoy Mullick, Jyoti Sutar, Nitin Hingankar, et al.
Plos One|August 30, 2018
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in IndiaSivasankaran Munusamy Ponnan, Soumya Swaminathan, Kannan Tiruvengadam, et al.
Pathogens and Disease|September 11, 2019
Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressorsChinnambedu Ravichandran Swathirajan, Pannerselvam Nandagopal, Ramachandran Vignesh, et al.
Plos One|March 29, 2019
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in IndiaSivasankaran Munusamy Ponnan, Sathyamurthy Pattabiram, Kannan Thiruvengadam, et al.
Plos One|April 21, 2025
Acceptability of broadly neutralizing antibodies (bNAbs) for HIV prevention among vulnerable populations in India: Findings from a qualitative studyJoyeeta Mukherjee, Saif Ul Hadi, Venkatesan Chakrapani, et al.
Journal of Virology|January 15, 2016
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 LoopShilpa Patil, Rajesh Kumar, Suprit Deshpande, et al.
Frontiers in Pharmacology|October 20, 2025
Exploring the pharmacokinetics, drug-likeness, and toxicological features of anticancer flavonoids: a Boulevard to explore their clinical translational potentialAnkit Kumar Dubey, Siva Sai Chandragiri, Abin V Geevarghese, et al.
Plos One|February 26, 2020
Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in IndiaSivasankaran Munusamy Ponnan, Peter Hayes, Natalia Fernandez, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Journal of General Virology|February 21, 2018
Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern IndiaPaneerselvam Nandagopal, Jayanta Bhattacharya, Aylur K Srikrishnan, et al.
Current Pharmaceutical Biotechnology|July 23, 2024
Decoding and Unravelling Mpox, Herpes, and Syphilis Infections: A State of Art ReviewJiao Wang, Rajat Goyal, Rupesh K Gautam, et al.
Retrovirology|May 15, 2021
Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificitiesRanajoy Mullick, Jyoti Sutar, Nitin Hingankar, et al.
Plos One|August 30, 2018
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in IndiaSivasankaran Munusamy Ponnan, Soumya Swaminathan, Kannan Tiruvengadam, et al.
Pathogens and Disease|September 11, 2019
Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressorsChinnambedu Ravichandran Swathirajan, Pannerselvam Nandagopal, Ramachandran Vignesh, et al.
Plos One|March 29, 2019
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in IndiaSivasankaran Munusamy Ponnan, Sathyamurthy Pattabiram, Kannan Thiruvengadam, et al.
Plos One|April 21, 2025
Acceptability of broadly neutralizing antibodies (bNAbs) for HIV prevention among vulnerable populations in India: Findings from a qualitative studyJoyeeta Mukherjee, Saif Ul Hadi, Venkatesan Chakrapani, et al.
Journal of Virology|January 15, 2016
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 LoopShilpa Patil, Rajesh Kumar, Suprit Deshpande, et al.
Frontiers in Pharmacology|October 20, 2025
Exploring the pharmacokinetics, drug-likeness, and toxicological features of anticancer flavonoids: a Boulevard to explore their clinical translational potentialAnkit Kumar Dubey, Siva Sai Chandragiri, Abin V Geevarghese, et al.
Plos One|February 26, 2020
Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in IndiaSivasankaran Munusamy Ponnan, Peter Hayes, Natalia Fernandez, et al.
Pageof 6